Table 6.
Drug | Recommended Dosage and Reference | |
---|---|---|
Opioids | Buprenorphine-HCl (partial mu-agonist) | 0.05–0.1 mg/kg SQ q8–12238 |
Buprenorphine (long-acting formulations; partial mu-agonist) | 0.5–1.0 mg/kg SQ (Bup-SR) q48-72 h 3.25 mg/kg SQ (Ethiqa-XR) q48-72 h | |
Butorphanol (partial mu-agonist) | 1–5 mg/kg SQ q4h328 | |
Morphine (full mu-agonist) | 2–5 mg/kg SQ q2-4h238 | |
Tramadol (full mu-agonist) | 5–40 mg/kg SQ, IP (dose frequency not determined)50,182 | |
Non-steroidal anti-inflammatories | Carprofen (COX-2 preferential) | 2.5–5 mg/kg SQ q24h328 |
Carprofen (long-acting formulation) | 15 mg/kg SQ q24h329 | |
Meloxicam (COX-2 preferential) | 1–5 mg/kg SQ q24h330 | |
Meloxicam (long-acting formulation) | 6 mg/kg SQ q24h329 | |
Ketoprofen (non-selective COX inhibitor) | 5 mg/kg SQ q12h50,83 | |
Flunixin (non-selective COX inhibitor) | 2.5 mg/kg SQ q12h50 | |
Firocoxib (COX-2 elective) | 10–20 mg/kg IP q24h331 | |
Local anesthetics | Lidocaine | 2–4 mg/kg SQ over planned incision site; not to exceed 10 mg/kg50 |
Bupivacaine | 1–2 mg/kg SQ over planned incision site; not to exceed 2 mg/kg.50 | |
Liposomal Bupivacaine | 6 mg/kg SQ243 | |
Other drugs | Gabapentin | 10–30 mg/kg IP182,250 |
Maropitant | 8 mg/kg IP252 |
This table is comprised of commonly used analgesic drugs and common dosages used in mice. IP = intraperitoneal; SQ = subcutaneous.